Use of effectors of glutaminyl and glutamate cyclases

Details for Australian Patent Application No. 2009227925 (hide)

Owner Probiodrug AG

Inventors Niestroj, Andre J.; Heiser, Ulrich; Schilling, Stephan; Hoffmann, Torsten; Demuth, Hans-Ulrich

Agent Watermark

Pub. Number AU-B-2009227925

Parent 2004237408

Filing date 23 October 2009

Wipo publication date 12 November 2009

Acceptance publication date 15 December 2011

International Classifications

C07D 233/54 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/00 (2006.01)

A61K 31/4178 (2006.01)

A61K 31/4184 (2006.01)

A61K 31/4188 (2006.01)

A61K 31/4192 (2006.01) - 1,2,3-Triazoles

A61K 31/4745 (2006.01)

C07F 9/572 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/59 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/6506 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/6561 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

5 November 2009 Complete Application Filed

12 November 2009 Application Open to Public Inspection

  Published as AU-B-2009227925

15 December 2011 Application Accepted

  Published as AU-B-2009227925

12 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009227926-Azeotrope-like compositions of 1-chloro-3,3,3,-trifluoropropene and methyl iodide

2009227924-Wall structure assembly